ArticleInternational journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics2026
Maternal serum thrombospondin-4 levels in placenta accreta spectrum: A case-control study.
Article in International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Placenta Accreta Spectrum: A Narrative Review of Clinical Management, Contemporary Innovations, And Global Challenges.International journal of medical science and dental health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study evaluates maternal serum thrombospondin-4 (TSP-4) levels in pregnancies complicated by placenta accreta spectrum (PAS) and examine their association with maternal and neonatal outcomes.
methodsThis prospective case-control study included 80 pregnancies, comprising 40 cases with PAS and 40 healthy controls. The study was conducted at Ankara Etlik City Hospital between June 2025 and March 2026. Maternal serum TSP-4 levels were measured by ELISA. Clinical, obstetric, maternal, and neonatal data were recorded. Univariable and multivariable logistic regression and receiver operating characteristic (ROC) curve analyses were performed, including comparison of a clinical model with and without TSP-4.
resultsMaternal serum TSP-4 levels were significantly higher in the PAS group than in controls (9.88 [9.38-10.00] vs. 7.83 [6.01-9.30] ng/mL; P < 0.001). PAS was associated with prolonged hospitalization, increased transfusion requirement, earlier delivery, lower birth weight, lower Apgar scores, higher neonatal intensive care unit admission rates, and increased rates of adverse maternal and neonatal composite outcomes. Within the PAS cohort, TSP-4 levels were not associated with composite adverse maternal outcome, PAS grade, or major neonatal outcomes. In multivariable analysis, TSP-4 was the only variable independently associated with PAS (adjusted odds ratio 1.863, 95% confidnece interval [CI] 1.308-2.651; P = 0.001). ROC analysis demonstrated moderate discriminative ability (area under the curve [AUC] 0.796, 95% CI 0.697-0.895). At a cutoff value of >9.47 ng/mL, sensitivity and specificity were 72.5% and 82.5%, respectively, yielding a positive likelihood ratio of 4.14 and a negative likelihood ratio of 0.33. Adding TSP-4 to the clinical model increased the AUC from 0.660 to 0.816 (P = 0.002 for the difference).
conclusionMaternal serum TSP-4 is elevated in PAS and, by adding discriminative value to clinical predictors, might be considered a complementary biomarker candidate for antenatal risk stratification, although these associations warrant confirmation in larger, prospective, multicenter cohorts. Its value appears greater for identifying disease presence than for reflecting disease severity.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.